Application of Item Response Theory to ADAS-cog Scores Modeling in Alzheimer s Disease
|
|
- Ralph Blankenship
- 5 years ago
- Views:
Transcription
1 Application of Item Response Theory to ADAS-cog Scores Modeling in Alzheimer s Disease Sebastian Ueckert 1, Elodie L. Plan 2, Kaori Ito 3, Mats O. Karlsson 1, Brian W. Corrigan 3, Andrew C. Hooker 1 1. Dept Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden 2. Metrum Institute and Metrum Research Group, Tariffville, CT, USA 3. Global Clinical Pharmacology, Pfizer Inc, Groton, CT, USA
2 Make a fist Draw a circle 7 June 2012 Name current month 2
3 ADAS-cog Assessment Cognitive subscale of Alzheimer s Disease Assessment Scale Cognitive assessment including broad range of sub-tests e.g., 7 June 2012 Make a fist Draw a circle Name current month LAKE CLOCK FOREST ANIMAL Name finger Name object Remember those words Foldput in envelopaddress stamp Ability to speak Ability to understand Rosen et al
4 ADAS-cog Assessment Cognitive subscale of Alzheimer s Disease Assessment Scale Cognitive assessment including broad range of sub-tests e.g., 7 June 2012 Make a fist Draw a circle Name current month Name finger Foldput in envelopaddress stamp Name object Ability to speak LAKE CLOCK FOREST ANIMAL Remember those words Ability to understand Primary outcome Range 0-70 Σ AD AD severity ADAS-cog Score Σ AD Rosen et al
5 ADAS-cog Assessment Cognitive subscale of Alzheimer s Disease Assessment Scale Cognitive assessment including broad range of sub-tests e.g., 7 June 2012 Make a fist Draw a circle Name current month Name finger Foldput in envelopaddress stamp Name object Ability to speak LAKE CLOCK FOREST ANIMAL Remember those words Ability to understand Σ AD Primary outcome Range 0-70 Σ AD AD severity ADAS-cog Score Σ AD t Rosen et al
6 Score Properties Tasks have varying difficulty e.g., construction or drawing task Non-linear scale Imputation necessary if subject refuses task or physician omits it Bias Object to Draw 0% 80% Fraction of Subjects Failing Task ADAS-cog in study A ADAS-cog in study B Different test versions (ADAS-cog11, ADAS-cogmod, ADAS-cog13, ADAS-cogMCI ) Hard to pool data 6
7 Cognitive Disability 7 June 2012 COGNITIVE DISABILITY LAKE CLOCK FOREST ANIMAL 7
8 Cognitive Disability 7 June 2012 COGNITIVE DISABILITY LAKE CLOCK FOREST ANIMAL 8
9 Cognitive Disability 7 June COGNITIVE DISABILITY LAKE CLOCK FOREST ANIMAL 9
10 Item Response Theory Georg Rasch Assumption: Paul Lazarsfeld Statistical framework to score tests or surveys consisting of several dichotomous (or polytomous) responses Developed around 1950 by Rasch and Lazarsfeld Individual responses for each item depend on a hidden variable (trait or ability) Describes the probability of a certain test outcome as the function of a person s ability Directly estimates the most likely ability, instead of summary scores Used in psychometrics for the development of high-stakes tests 10
11 Project Outline Assumption: Outcome of each test in the ADAS-cog assessment depends on unobserved variable cognitive disability Approach: 1. Develop IRT model for ADAS-cog assessment using data from clinical trial databases 2. Apply ADAS-cog IRT model to longitudinal clinical trial data 3. Investigate benefits of IRT model 11
12 Baseline Model 12
13 Data Observational study with normal, mild cognitively impaired (MCI) and mild AD subjects Baseline ADAS-cog data 819 subjects Database with placebo arm data from clinical trials First visit ADAS-cog data from 6* CAMD studies (Phase II & III) 1832 subjects > data entries in total adni-info.org *Studies with item level data as of November
14 Model 7 June 2012 COGNITIVE DISABILITY LAKE CLOCK FOREST ANIMAL 14
15 Model 7 June 2012 LAKE CLOCK FOREST ANIMAL 15
16 P(not Drawing Cube Correctly) P(not Drawing Cube Correctly) P(not Drawing Cube Correctly) Model Test specific Binary Subject specific 80% 60% 40% 20% 80% 60% 40% 20% Parameter Value Cognitive Disability Parameter Value Cognitive Disability 80% 60% 40% 20% Parameter Value Cognitive Disability
17 Model Binary (x 39) Binomial (x 3) Ordered Categorical (x 5) Generalized Poisson (x 1) 167 Parameters 166 fixed effect 1 random effect 17
18 Ordered Categorical P(Y ji =k) Binomial P(Failed) Binary P(Failed) Results Commands Construction Ideational Praxis Orientation Naming Word Recall Delayed Word Recall Word Recognition Number Cancellation Comprehension Concentration Remembering Word Finding Spoken Language
19 Longitudinal Model 19
20 Data Placebo arm of Phase III study with mild to moderate AD patients 18 month with 6 ADAS-cog assessments 322 subjects observations in total 20
21 Model Binary (x 39) Binomial (x 3) Ordered Categorical (x 5) Generalized Poisson (x 1) 21
22 Model Binary (x 39) Binomial (x 3) Ordered Categorical (x 5) Generalized Poisson 5 Parameters 2 fixed effect 2 random effect 1 covariance (x 1) 22
23 Results All parameters estimated precisely (assessed through - Hessian of log-likelihood) Corresponding to baseline ADAS-cog value of 22.2 points and yearly increase of 3.5 points Parameter Value RSE Baseline θ % Slope θ % IIV Baseline ω % IIV Slope ω % Cor(η 1,η 2 ) % 23
24 Fraction ADAS-cog Score Fraction Failed Diagnostics Summary Score Commands Test Make a fist Point to ceiling Put pencil Put watch Tap shoulder Word Recall Test Time [days] Time [days] Y=0 Y=1 Y=2 Y=3 Y=4 Y=5 Y=6 Y=7 Y=8 Y=9 Y= Time [days] Repetition 1 Y = Number not recalled words
25 Benefits of the IRT Approach 25
26 Density Handle the True Nature of the Score Occasion 1 Occasion 2 Occasion Occasion 4 Occasion 5 Occasion 6 Observed Simulated ADAS-cog Score Bounded nature of each subcomponent is taken into account Summary score distribution is more natural 26
27 Power Increased Power Method: 1. Simulation from longitudinal IRT model with disease modifying drug effect of 20 % (n=500) 2. Estimation with full and reduced IRT model 3. Estimation with full and reduced Summary Score model 80% 60% 40% Increased Power when using IRT model Approach Number of Individuals Summary Score IRT 27
28 Power Improved Clinical Trial Simulations ADAS-cog 11 ADAS-cog 13 Approach delivers test & subject specific parameters Simulate different populations & different ADAS-cog assessments 90 % 80 % 70 % 84 % 85 % 86 % 87 % Mild AD MCI *600 Subjects (300/300), 20% drug effect DM 28
29 Integrating Information Across Trials Combination of data across trials easily possible Other cognitive tests like MMSE can be related to same hidden variable MMSE assessments become additional observations ADAS-cog13 ADAS-cog11 * Work in Progress ADAS-cog COGNITIVE DISABILITY * MMSE ADAS-cogmod ADAS-cogmci 29
30 Advanced Optimal Trial Design COGNITIVE DISABILITY Each response function is dependent on D Calculate Fisher Information for each item: Measure of information content in each item 30
31 Information Item Information Commands Comprehension Concentration Construction Delayed Word Recall Ideational Praxis Naming Orientation Remembering Spoken Language Word Finding Word Recall Word Recognition Cognitive Disability
32 Information Information for a MCI Study Commands Comprehension Concentration Construction Delayed Word Recall Ideational Praxis Naming Orientation Remembering Spoken Language Word Finding Word Recall Word Recognition Cognitive Disability
33 Component Ranking for MCI Study Test Information Delayed Word Recall Word Recall Orientation Word Recognition Naming Number Cancellation Construction Word Finding Allows adaptation of the test to a specific population Test can be performed quicker with little change in information content Ideational Praxis Concentration Remembering Comprehension Commands Spoken Language
34 Summary Extension: UPDRS IRT Model Parkinson s Model ACR IRT Model Drug Effect Model Advantages Treat true nature of data (better simulation properties) Increased drug effect detection power More flexible clinical trial simulations Possibility to optimize test design Implicit mechanism for missing sub-scores Rheumatoid Arthritis Model Drug Effect Model 34
35 Acknowledgements Colleagues in Uppsala Pfizer colleagues in Groton 35
Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling
Pharm Res (2014) 31:2152 2165 DOI 10.1007/s11095-014-1315-5 RESEARCH PAPER Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling Sebastian Ueckert
More informationUtilizing the items from the MDS-UPDRS score to increase drug effect detection power in de novo idiopathic Parkinson's disease patients
Utilizing the items from the MDS-UPDRS score to increase drug effect detection power in de novo idiopathic Parkinson's disease patients Simon Buatois 1,3, Sylvie Retout 1, Nicolas Frey 1, Sebastian Ueckert
More informationComposite Clinical Score Assessment through Item Response Theory-Based Pharmacometric Modeling
Composite Clinical Score Assessment through Item Response Theory-Based Pharmacometric Modeling Sebastian Ueckert, PhD Researcher Pharmacometric Research Group Department of Pharmaceutical Biosciences Uppsala
More informationNew scoring methodology improves the sensitivity of the Alzheimer s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials
Verma et al. Alzheimer's Research & Therapy (2015) 7:64 DOI 10.1186/s13195-015-0151-0 RESEARCH Open Access New scoring methodology improves the sensitivity of the Alzheimer s Disease Assessment Scale-Cognitive
More informationAn integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease
An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease Angelica Quartino 1* Dan Polhamus 2*, James Rogers 2, Jin Jin 1 212, Genentech
More informationCritical Path Institute Coalition Against Major Diseases (CAMD) Alzheimer s Clinical Trial Database
Critical Path Institute Coalition Against Major Diseases (CAMD) Alzheimer s Clinical Trial Database Dr. Carolyn Compton, M.D., Ph.D. Chief Executive Officer Critical Path Institute 1 What We Do DEVELOP
More informationModeling disease progression in acute stroke by simultaneously using the NIH Stroke Scale, Scandinavian Stroke Scale and the Barthel Index
Modeling disease progression in acute stroke by simultaneously using the NIH Stroke Scale, Scandinavian Stroke Scale and the Barthel Index Kristin E. Karlsson Justin J. Wilkins, Mats O. Karlsson and E.
More informationItem response theory analysis of cognitive tests in people with dementia: a systematic review
McGrory et al. BMC Psychiatry 2014, 14:47 RESEARCH ARTICLE Open Access Item response theory analysis of cognitive tests in people with dementia: a systematic review Sarah McGrory 1*, Jason M Doherty 2,
More informationAD Prevention Trials: An Industry Perspective
AD Prevention Trials: An Industry Perspective Robert A. Lasser, MD, MBA Global Development Lead, Product Development Group Medical Director, Neurodegenerative Disorders F. Hoffmann - La Roche Ltd Regulatory
More informationRada Savic 1 Alain Munafo 2, Mats Karlsson 1
Population Pharmacodynamics of Cladribine Tablets Therapy in Patients with Multiple Sclerosis: Relationship between Magnetic Resonance Imaging and Clinical Outcomes Rada Savic 1 Alain Munafo 2, Mats Karlsson
More informationContents. What is item analysis in general? Psy 427 Cal State Northridge Andrew Ainsworth, PhD
Psy 427 Cal State Northridge Andrew Ainsworth, PhD Contents Item Analysis in General Classical Test Theory Item Response Theory Basics Item Response Functions Item Information Functions Invariance IRT
More informationPresented By: Yip, C.K., OT, PhD. School of Medical and Health Sciences, Tung Wah College
Presented By: Yip, C.K., OT, PhD. School of Medical and Health Sciences, Tung Wah College Background of problem in assessment for elderly Key feature of CCAS Structural Framework of CCAS Methodology Result
More informationData harmonization tutorial:teaser for FH2019
Data harmonization tutorial:teaser for FH2019 Alden Gross, Johns Hopkins Rich Jones, Brown University Friday Harbor Tahoe 22 Aug. 2018 1 / 50 Outline Outline What is harmonization? Approach Prestatistical
More informationInstitute of Medicine Workshop: DIGITAL DATA PRIORITIES FOR CONTINUOUS LEARNING IN HEALTH AND HEALTH CARE
Institute of Medicine Workshop: DIGITAL DATA PRIORITIES FOR CONTINUOUS LEARNING IN HEALTH AND HEALTH CARE Data Quality in Clinical Research 23 March 2012 Rebecca D. Kush, PhD President and CEO, CDISC CDISC
More informationThe Rest is Noise. The Promise of ecoa in Increasing Signal Detection
Medavante Research White paper The Rest is Noise The Promise of ecoa in Increasing Signal Detection By Christopher Randolph, PhD, ABPP-CN Medical Director of Neuropsychology, Loyola University Medical
More informationItem Analysis: Classical and Beyond
Item Analysis: Classical and Beyond SCROLLA Symposium Measurement Theory and Item Analysis Modified for EPE/EDP 711 by Kelly Bradley on January 8, 2013 Why is item analysis relevant? Item analysis provides
More informationTutorial: Introduction to Markov modelling
Tutorial: Introduction to Markov modelling Mats O Karlsson Pharmacometrics Research Group Department of Pharmaceutical Biosciences Uppsala University Sweden Coin toss Assume a coin has been tossed n times
More informationHow do we combine two treatment arm trials with multiple arms trials in IPD metaanalysis? An Illustration with College Drinking Interventions
1/29 How do we combine two treatment arm trials with multiple arms trials in IPD metaanalysis? An Illustration with College Drinking Interventions David Huh, PhD 1, Eun-Young Mun, PhD 2, & David C. Atkins,
More informationIdentification of Cognitive Impairment in HIV patients. Belinda Vicioso MD FACP, AGSF Jose Garcia Professor of Medicine UTSW
Identification of Cognitive Impairment in HIV patients Belinda Vicioso MD FACP, AGSF Jose Garcia Professor of Medicine UTSW New emphasis on cognition Why? Common in our patient population Often overlooked
More informationEngineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos,
Engineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos, Susan Resnik, Sterling Johnson, and Pierre Jedynak Longitudinal
More informationOn indirect measurement of health based on survey data. Responses to health related questions (items) Y 1,..,Y k A unidimensional latent health state
On indirect measurement of health based on survey data Responses to health related questions (items) Y 1,..,Y k A unidimensional latent health state A scaling model: P(Y 1,..,Y k ;α, ) α = item difficulties
More informationBayesian approaches to handling missing data: Practical Exercises
Bayesian approaches to handling missing data: Practical Exercises 1 Practical A Thanks to James Carpenter and Jonathan Bartlett who developed the exercise on which this practical is based (funded by ESRC).
More informationBuilding Evaluation Scales for NLP using Item Response Theory
Building Evaluation Scales for NLP using Item Response Theory John Lalor CICS, UMass Amherst Joint work with Hao Wu (BC) and Hong Yu (UMMS) Motivation Evaluation metrics for NLP have been mostly unchanged
More informationCentre for Education Research and Policy
THE EFFECT OF SAMPLE SIZE ON ITEM PARAMETER ESTIMATION FOR THE PARTIAL CREDIT MODEL ABSTRACT Item Response Theory (IRT) models have been widely used to analyse test data and develop IRT-based tests. An
More informationCatherine A. Welch 1*, Séverine Sabia 1,2, Eric Brunner 1, Mika Kivimäki 1 and Martin J. Shipley 1
Welch et al. BMC Medical Research Methodology (2018) 18:89 https://doi.org/10.1186/s12874-018-0548-0 RESEARCH ARTICLE Open Access Does pattern mixture modelling reduce bias due to informative attrition
More informationTurning Output of Item Response Theory Data Analysis into Graphs with R
Overview Turning Output of Item Response Theory Data Analysis into Graphs with R Motivation Importance of graphing data Graphical methods for item response theory Why R? Two examples Ching-Fan Sheu, Cheng-Te
More informationTechnical Specifications
Technical Specifications In order to provide summary information across a set of exercises, all tests must employ some form of scoring models. The most familiar of these scoring models is the one typically
More informationA Bayesian Nonparametric Model Fit statistic of Item Response Models
A Bayesian Nonparametric Model Fit statistic of Item Response Models Purpose As more and more states move to use the computer adaptive test for their assessments, item response theory (IRT) has been widely
More informationMissing Data and Imputation
Missing Data and Imputation Barnali Das NAACCR Webinar May 2016 Outline Basic concepts Missing data mechanisms Methods used to handle missing data 1 What are missing data? General term: data we intended
More informationIntroduction to Test Theory & Historical Perspectives
Introduction to Test Theory & Historical Perspectives Measurement Methods in Psychological Research Lecture 2 02/06/2007 01/31/2006 Today s Lecture General introduction to test theory/what we will cover
More informationNEUROPSYCHOMETRIC TESTS
NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract
More informationMigrating from UDS 2.0 to UDS 3.0: Modern psychometric methods. Paul K. Crane, MD MPH Department of Medicine University of Washington
Migrating from UDS 2.0 to UDS 3.0: Modern psychometric methods Paul K. Crane, MD MPH Department of Medicine University of Washington ADC Directors Meeting, San Diego, CA, September 2011 General introduction
More informationInstrumental Variables Estimation: An Introduction
Instrumental Variables Estimation: An Introduction Susan L. Ettner, Ph.D. Professor Division of General Internal Medicine and Health Services Research, UCLA The Problem The Problem Suppose you wish to
More informationAdaptive Design in CIAS
Adaptive Design in CIAS or If you don t know where you re going, any road will get you there Michael Sand, PhD, MPH Senior Clinical Program Leader, CNS Boehringer Ingelheim Disclosures I m an employee
More informationBioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer s disease presented at AAIC 2018
Press release BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer s disease presented at AAIC 2018 Stockholm, Sweden, July 25, 2018 BioArctic AB (publ) (Nasdaq Stockholm:
More informationClinical Pharmacology. Clinical Pharmacology = Disease Progress + Drug Action. Outline. Disease Progress and Drug Action
1 Clinical Pharmacology Disease Progress and Drug Action Nick Holford Dept Pharmacology and Clinical Pharmacology University of Auckland 2 Clinical Pharmacology = Disease Progress + Drug Action Clinical
More informationsammanchester Assessing Cognition in Emergency and Acute Medicine September 2015
sammanchester 10 11 September 2015 Assessing Cognition in Emergency and Acute Medicine. Dr. Austin Claffey Senior Lecturer in Occupational Therapy London South Bank University. Assumptions Underlying neuropsychological
More informationWHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014
WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014 1. Introduction This release consists of a single data set from the WHIMS Epidemiology of Cognitive Health Outcomes
More informationBiostatistics II
Biostatistics II 514-5509 Course Description: Modern multivariable statistical analysis based on the concept of generalized linear models. Includes linear, logistic, and Poisson regression, survival analysis,
More informationBioArctic announces positive topline results of BAN2401 Phase 2b at 18 months in early Alzheimer s Disease
Press release BioArctic announces positive topline results of BAN2401 Phase 2b at 18 months in early Alzheimer s Disease The full 18 month analysis of the 856 patient BAN2401 Phase 2b clinical study in
More informationAssessing cognitive function after stroke. Glyn Humphreys
Assessing cognitive function after stroke Glyn Humphreys (glyn.humphreys@psy.ox.ac.uk) Write down 3 important cognitive problems after stroke What things are important to detect? OCS Impairment incidences
More informationNeuropsychological Evaluation of
Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish
More informationA model-based analysis to describe bedaquiline s exposure-response relationship and predict the impact of drugdrug interactions
9th International Workshop on Clinical Pharmacology of TB Drugs 24 October 2016, Liverpool, UK A model-based analysis to describe bedaquiline s exposure-response relationship and predict the impact of
More informationPharmaceutical Statistics Journal Club 15 th October Missing data sensitivity analysis for recurrent event data using controlled imputation
Pharmaceutical Statistics Journal Club 15 th October 2015 Missing data sensitivity analysis for recurrent event data using controlled imputation Authors: Oliver Keene, James Roger, Ben Hartley and Mike
More informationPopulation pharmacokinetics of bedaquiline (TMC207) and its M2 and M3 metabolites with efavirenz demonstrate reduced exposure
Population pharmacokinetics of bedaquiline (TMC207) and its M2 and M3 metabolites with efavirenz demonstrate reduced exposure Elin M Svensson 1 Kelly E Dooley 2, Francesca Aweeka 3, Jeong-Gun Park 4, Mats
More informationModeling Composite Assessment Data Using Item Response Theory
Citation: CPT Pharmacometrics Syst. Pharmacol. (2018) 7, 205 218; VC 2018 ASCPT All rights reserved doi:10.1002/psp4.12280 TUTORIAL Modeling Composite Assessment Data Using Item Response Theory Sebastian
More informationDescription of components in tailored testing
Behavior Research Methods & Instrumentation 1977. Vol. 9 (2).153-157 Description of components in tailored testing WAYNE M. PATIENCE University ofmissouri, Columbia, Missouri 65201 The major purpose of
More informationBruno D. Zumbo, Ph.D. University of Northern British Columbia
Bruno Zumbo 1 The Effect of DIF and Impact on Classical Test Statistics: Undetected DIF and Impact, and the Reliability and Interpretability of Scores from a Language Proficiency Test Bruno D. Zumbo, Ph.D.
More informationApplied Medical. Statistics Using SAS. Geoff Der. Brian S. Everitt. CRC Press. Taylor Si Francis Croup. Taylor & Francis Croup, an informa business
Applied Medical Statistics Using SAS Geoff Der Brian S. Everitt CRC Press Taylor Si Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Croup, an informa business A
More informationOn Test Scores (Part 2) How to Properly Use Test Scores in Secondary Analyses. Structural Equation Modeling Lecture #12 April 29, 2015
On Test Scores (Part 2) How to Properly Use Test Scores in Secondary Analyses Structural Equation Modeling Lecture #12 April 29, 2015 PRE 906, SEM: On Test Scores #2--The Proper Use of Scores Today s Class:
More informationOutline. Hierarchical Hidden Markov Models for HIV-Transmission Behavior Outcomes. Motivation. Why Hidden Markov Model? Why Hidden Markov Model?
Hierarchical Hidden Markov Models for HIV-Transmission Behavior Outcomes Li-Jung Liang Department of Medicine Statistics Core Email: liangl@ucla.edu Joint work with Rob Weiss & Scott Comulada Outline Motivation
More informationData Analysis Using Regression and Multilevel/Hierarchical Models
Data Analysis Using Regression and Multilevel/Hierarchical Models ANDREW GELMAN Columbia University JENNIFER HILL Columbia University CAMBRIDGE UNIVERSITY PRESS Contents List of examples V a 9 e xv " Preface
More informationMINI MENTAL STATE EXAM
MINI MENTAL STATE EXAM ID NUMBER: FORM CODE: M M E DATE: 06/01/2011 Version 2.0 ADMINISTRATIVE INFORMATION 0a. Completion Date: / / 0b. Staff ID: Month Day Year Materials: Black pen, pencil, wrist watch,
More informationGraphical display of population data
Graphical display of population data E. Niclas Jonsson Division of Pharmacokinetics and Drug Therapy Department of Pharmaceutical Biosciences Uppsala University Nature of population data Hierarchical Variable
More informationOverview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?
Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric
More informationMethods for Computing Missing Item Response in Psychometric Scale Construction
American Journal of Biostatistics Original Research Paper Methods for Computing Missing Item Response in Psychometric Scale Construction Ohidul Islam Siddiqui Institute of Statistical Research and Training
More informationBEST PRACTICES FOR IMPLEMENTATION AND ANALYSIS OF PAIN SCALE PATIENT REPORTED OUTCOMES IN CLINICAL TRIALS
BEST PRACTICES FOR IMPLEMENTATION AND ANALYSIS OF PAIN SCALE PATIENT REPORTED OUTCOMES IN CLINICAL TRIALS Nan Shao, Ph.D. Director, Biostatistics Premier Research Group, Limited and Mark Jaros, Ph.D. Senior
More informationParameter Estimation of Cognitive Attributes using the Crossed Random- Effects Linear Logistic Test Model with PROC GLIMMIX
Paper 1766-2014 Parameter Estimation of Cognitive Attributes using the Crossed Random- Effects Linear Logistic Test Model with PROC GLIMMIX ABSTRACT Chunhua Cao, Yan Wang, Yi-Hsin Chen, Isaac Y. Li University
More informationBRIEF Kingston Standardized Cognitive Assessment - revised
BRIEF Kingston Standardized Cognitive Assessment - revised (BriefKSCAr) Administration and Scoring Manual Geriatric Psychiatry Programme, Providence Care, Mental Health Services, Kingston, Canada K7L 4X3
More informationModel-Based Drug Development. Russell Reeve, Innovation, Quintiles May 22, 2012 Society of Clinical Trials
Model-Based Drug Development Russell Reeve, Innovation, Quintiles May 22, 2012 Society of Clinical Trials Disclaimer and Acknowledgments Disclaimer Views presented herein are mine alone, and do not necessarily
More informationProcess of a neuropsychological assessment
Test selection Process of a neuropsychological assessment Gather information Review of information provided by referrer and if possible review of medical records Interview with client and his/her relative
More informationModule 14: Missing Data Concepts
Module 14: Missing Data Concepts Jonathan Bartlett & James Carpenter London School of Hygiene & Tropical Medicine Supported by ESRC grant RES 189-25-0103 and MRC grant G0900724 Pre-requisites Module 3
More informationS Imputation of Categorical Missing Data: A comparison of Multivariate Normal and. Multinomial Methods. Holmes Finch.
S05-2008 Imputation of Categorical Missing Data: A comparison of Multivariate Normal and Abstract Multinomial Methods Holmes Finch Matt Margraf Ball State University Procedures for the imputation of missing
More informationStatistical Analysis to identify discriminant progression factors of the Parkinson s disease
Statistical Analysis to identify discriminant progression factors of the Parkinson s disease Ana Rita Sousa Instituto Superior Técnico, TULisbon Lisboa, Portugal anaritasousa@ist.utl.pt ABSTRACT The Parkinson
More informationAIMS2 USER'S GUIDE BOSTON UNIVERSITY ARTHRITIS CENTER
AIMS2 USER'S GUIDE BOSTON UNIVERSITY ARTHRITIS CENTER The second version of the Arthritis Impact Measurement Scales (AIMS2) is an improvement on an evaluation instrument that was developed to measure patient
More informationDefinitive QTc Assessment in Early Phase Trials: Expectations from FDA s Interdisciplinary Review Team
Definitive QTc Assessment in Early Phase Trials: Expectations from FDA s Interdisciplinary Review Team Jiang Liu, Ph.D. Scientific Lead for QT-IRT Division of Pharmacometrics Office of Clinical Pharmacology
More informationCertificate Courses in Biostatistics
Certificate Courses in Biostatistics Term I : September December 2015 Term II : Term III : January March 2016 April June 2016 Course Code Module Unit Term BIOS5001 Introduction to Biostatistics 3 I BIOS5005
More informationSelection and Combination of Markers for Prediction
Selection and Combination of Markers for Prediction NACC Data and Methods Meeting September, 2010 Baojiang Chen, PhD Sarah Monsell, MS Xiao-Hua Andrew Zhou, PhD Overview 1. Research motivation 2. Describe
More informationTable of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix
Table of Contents Preface to the third edition xiii Preface to the second edition xv Preface to the fi rst edition xvii List of abbreviations xix PART 1 Developing and Validating Instruments for Assessing
More informationUtilizing the NIH Patient-Reported Outcomes Measurement Information System
www.nihpromis.org/ Utilizing the NIH Patient-Reported Outcomes Measurement Information System Thelma Mielenz, PhD Assistant Professor, Department of Epidemiology Columbia University, Mailman School of
More informationA Longitudinal Item Response Theory Model to Characterize Cognition Over Time in Elderly Subjects
Citation: CPT Pharmacometrics Syst. Pharmacol. (2017) 6, 635 641; VC 2017 ASCPT All rights reserved doi:10.1002/psp4.12219 ORIGINAL ARTICLE A Longitudinal Item Response Theory Model to Characterize Cognition
More informationRunning head: NESTED FACTOR ANALYTIC MODEL COMPARISON 1. John M. Clark III. Pearson. Author Note
Running head: NESTED FACTOR ANALYTIC MODEL COMPARISON 1 Nested Factor Analytic Model Comparison as a Means to Detect Aberrant Response Patterns John M. Clark III Pearson Author Note John M. Clark III,
More informationAging: Tools for Assessment
Aging: Tools for Assessment Eugenia L. Siegler, MD Mason Adams Professor of Geriatric Medicine Weill Cornell Medicine New York, New York San Antonio, Texas: August 21 to 23, 2017 Learning Objectives After
More informationMeta-analyses of clinical dose response
Meta-analyses of clinical dose response N. Thomas 1 D. Roy, V. Somayaji, and K. Sweeney 1 Pfizer Inc 445 Eastern Point Road Groton, CT 06340 EMA/EFPIA, 2014 Thomas, Roy, Somayaji, Sweeney (Pfizer) Meta-analyses
More informationUniversity of Texas, MD Anderson Cancer Center
University of Texas, MD Anderson Cancer Center UT MD Anderson Cancer Center Department of Biostatistics Working Paper Series Year 2007 Paper 39 The Effect of Population Drift on Adaptively Randomized Trials
More informationCognitive Assessment 4/29/2015. Learning Objectives To be able to:
Supporting the Desire to Age in Place: Important Considerations for the Aging Population AGENDA 8:45 9:00 AM Geriatric Principles Robert L. Kane, MD *9:00 9:55 AM Cognitive Assessments Ed Ratner, MD 10:00
More informationA COMPARISON OF IMPUTATION METHODS FOR MISSING DATA IN A MULTI-CENTER RANDOMIZED CLINICAL TRIAL: THE IMPACT STUDY
A COMPARISON OF IMPUTATION METHODS FOR MISSING DATA IN A MULTI-CENTER RANDOMIZED CLINICAL TRIAL: THE IMPACT STUDY Lingqi Tang 1, Thomas R. Belin 2, and Juwon Song 2 1 Center for Health Services Research,
More informationMissing data. Patrick Breheny. April 23. Introduction Missing response data Missing covariate data
Missing data Patrick Breheny April 3 Patrick Breheny BST 71: Bayesian Modeling in Biostatistics 1/39 Our final topic for the semester is missing data Missing data is very common in practice, and can occur
More informationSelection and estimation in exploratory subgroup analyses a proposal
Selection and estimation in exploratory subgroup analyses a proposal Gerd Rosenkranz, Novartis Pharma AG, Basel, Switzerland EMA Workshop, London, 07-Nov-2014 Purpose of this presentation Proposal for
More informationStructural Equation Modeling (SEM)
Structural Equation Modeling (SEM) Today s topics The Big Picture of SEM What to do (and what NOT to do) when SEM breaks for you Single indicator (ASU) models Parceling indicators Using single factor scores
More informationA NOVEL PHARMACODYNAMIC MODEL FOR TREATMENT OF TUBERCULOSIS USING DAYS TO POSITIVITY IN AUTOMATED LIQUID MYCOBACTERIAL CULTURE
A NOVEL PHARMACODYNAMIC MODEL FOR TREATMENT OF TUBERCULOSIS USING DAYS TO POSITIVITY IN AUTOMATED LIQUID MYCOBACTERIAL CULTURE Emmanuel Chigutsa 1, Kashyap Patel 2, Marianne Visser 3, Gary Maartens 1,
More informationCan aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators
Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators ASPREE Randomized, double-blind, placebo-controlled trial for extending healthy
More informationAdaptive Testing With the Multi-Unidimensional Pairwise Preference Model Stephen Stark University of South Florida
Adaptive Testing With the Multi-Unidimensional Pairwise Preference Model Stephen Stark University of South Florida and Oleksandr S. Chernyshenko University of Canterbury Presented at the New CAT Models
More informationCTFPHC Working Group Members:
Cognitive Impairment - Guideline Presentation Speaker deck OVERVIEW We will review the following: 1. Background on Cognitive Impairment 2. Methods of the CTFPHC 3. Recommendations and Key Findings 4. Implementation
More informationIan McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University
Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview
More informationCOMBINING SCALING AND CLASSIFICATION: A PSYCHOMETRIC MODEL FOR SCALING ABILITY AND DIAGNOSING MISCONCEPTIONS LAINE P. BRADSHAW
COMBINING SCALING AND CLASSIFICATION: A PSYCHOMETRIC MODEL FOR SCALING ABILITY AND DIAGNOSING MISCONCEPTIONS by LAINE P. BRADSHAW (Under the Direction of Jonathan Templin and Karen Samuelsen) ABSTRACT
More informationUnderstandable Statistics
Understandable Statistics correlated to the Advanced Placement Program Course Description for Statistics Prepared for Alabama CC2 6/2003 2003 Understandable Statistics 2003 correlated to the Advanced Placement
More informationYour submission states that the adjusted indirect comparison methodology was based largely on the publication by Glenny et al
Clarification of the indirect comparison Your submission states that the adjusted indirect comparison methodology was based largely on the publication by Glenny et al Your methodology is as follows: An
More informationDecision consistency and accuracy indices for the bifactor and testlet response theory models
University of Iowa Iowa Research Online Theses and Dissertations Summer 2014 Decision consistency and accuracy indices for the bifactor and testlet response theory models Lee James LaFond University of
More information19th AWCBR (Australian Winter Conference on Brain Research), 2001, Queenstown, AU
19th AWCBR (Australian Winter Conference on Brain Research), 21, Queenstown, AU https://www.otago.ac.nz/awcbr/proceedings/otago394614.pdf Do local modification rules allow efficient learning about distributed
More informationThe Effects of the Calcium Binding Protein Apoaequorin on Memory and Cognitive Functioning in Older Adults
QUINCY BIOSCIENCE http://www.quincybioscience.com/research The Effects of the Calcium Binding Protein Apoaequorin on Memory and Cognitive Functioning in Older Adults Mark Y. Underwood, Peggy A. Sivesind,
More informationCenter for Advanced Studies in Measurement and Assessment. CASMA Research Report
Center for Advanced Studies in Measurement and Assessment CASMA Research Report Number 39 Evaluation of Comparability of Scores and Passing Decisions for Different Item Pools of Computerized Adaptive Examinations
More informationAnalyzing diastolic and systolic blood pressure individually or jointly?
Analyzing diastolic and systolic blood pressure individually or jointly? Chenglin Ye a, Gary Foster a, Lisa Dolovich b, Lehana Thabane a,c a. Department of Clinical Epidemiology and Biostatistics, McMaster
More informationDifferential Item Functioning
Differential Item Functioning Lecture #11 ICPSR Item Response Theory Workshop Lecture #11: 1of 62 Lecture Overview Detection of Differential Item Functioning (DIF) Distinguish Bias from DIF Test vs. Item
More informationMontreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013
Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013 1 MoCA 2 Overview of the MoCA Takes approximately 15 minutes to administer Requires
More informationDevelopment, Standardization and Application of
American Journal of Educational Research, 2018, Vol. 6, No. 3, 238-257 Available online at http://pubs.sciepub.com/education/6/3/11 Science and Education Publishing DOI:10.12691/education-6-3-11 Development,
More informationExposure-response in the presence of confounding
Exposure-response in the presence of confounding Jonathan L. French, ScD Metrum Research Group LLC May 3, 2016 c 2016 Metrum Research Group LLC TICTS, Durham, NC, 2016 May 3, 2016 1 / 24 Outline 1 Introduction
More informationReferences. Embretson, S. E. & Reise, S. P. (2000). Item response theory for psychologists. Mahwah,
The Western Aphasia Battery (WAB) (Kertesz, 1982) is used to classify aphasia by classical type, measure overall severity, and measure change over time. Despite its near-ubiquitousness, it has significant
More informationEstimating drug effects in the presence of placebo response: Causal inference using growth mixture modeling
STATISTICS IN MEDICINE Statist. Med. 2009; 28:3363 3385 Published online 3 September 2009 in Wiley InterScience (www.interscience.wiley.com).3721 Estimating drug effects in the presence of placebo response:
More informationThe RoB 2.0 tool (individually randomized, cross-over trials)
The RoB 2.0 tool (individually randomized, cross-over trials) Study design Randomized parallel group trial Cluster-randomized trial Randomized cross-over or other matched design Specify which outcome is
More information